Two New Patents — Extending Our Platform into Cancer Immunotherapy and ALDH2 Deficiency | Sen-Jam Pharmaceutical
https://wefunder.com/feed/344511
Published at: 2026-06-27 19:30:18 UTC
Subject: Sen-Jam Pharmaceutical
Dear WeFunder Investors and Community, A quick update on our intellectual property. In June we filed two new U.S. provisional patent applications, broadening the portfolio around Sen-Jam’s anti-inflammatory platform. SJP-015PR — immune-related adv...